Authors

• Lea Dutta (ORCID: https://orcid.org/0000-0003-2864-3617)
• Antonio González-Martı́n (ORCID: https://orcid.org/0000-0001-8376-9576)
• Chinyere E. Okpara (ORCID: https://orcid.org/0000-0002-5621-9138)
• Alexandra Léary (ORCID: https://orcid.org/0000-0002-2043-2244)
• Bradley R. Corr (ORCID: https://orcid.org/0000-0002-6608-2585)
• Xiaohua Wu (ORCID: https://orcid.org/0000-0002-7664-8327)
• Helen J MacKay (ORCID: https://orcid.org/0000-0001-6220-1789)
• Domenica Lorusso (ORCID: https://orcid.org/0000-0003-0981-0598)
• Ramez N. Eskander (ORCID: https://orcid.org/0000-0002-2101-1935)
• Jodi A. McKenzie (ORCID: https://orcid.org/0000-0002-6345-1218)
• Isabelle Laure Ray-Coquard (ORCID: https://orcid.org/0000-0003-2472-8306)
• Jung‐Yun Lee (ORCID: https://orcid.org/0000-0001-7948-1350)
• Vicky Makker (ORCID: https://orcid.org/0000-0001-9793-7614)
• Mansoor Raza Mirza
• Kosei Hasegawa (ORCID: https://orcid.org/0000-0002-1903-7001)
• Tianle Hu
• Ana Oaknin

Institutions

• Université Claude Bernard Lyon 1 (FR)
• Sunnybrook Health Science Centre (CA)
• Memorial Sloan Kettering Cancer Center (US)
• Humanitas University (IT)
• Inserm (FR)
• Yonsei University (KR)
• Cornell University (US)
• UC San Diego Health System (US)
• Institut Gustave Roussy (FR)
• Rigshospitalet (DK)
• University of California San Diego (US)
• Fudan University Shanghai Cancer Center (CN)
• Centre Léon Bérard (FR)
• Health Services and Performance Research Laboratory (FR)
• Vall d'Hebron Hospital Universitari (ES)
• Clinica Universidad de Navarra (ES)
• Gangnam Severance Hospital (KR)
• Eisai (United Kingdom) (GB)
• Eisai (United States) (US)
• Research on healthcare performance (FR)
• University of Colorado Anschutz Medical Campus (US)
• Eisai (Japan) (JP)
• Saitama Medical University (JP)

Publication Details

Journal

International Journal of Gynecological Cancer

Published

2025-04-06

DOI

https://doi.org/10.1016/j.ijgc.2025.101812

Primary Topic

Endometrial and Cervical Cancer Treatments

Type

article

Field-Weighted Citation Impact

0.00

Funders

• AbbVie
• Eisai Incorporated